Coopersburg, PA, United States of America

Daniel D Roth

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Daniel D. Roth in Pneumococcal Vaccines**

Introduction

Daniel D. Roth, an accomplished inventor based in Coopersburg, PA, has made significant contributions to the field of immunology through his innovative work at Merck Sharp & Dohme Corporation. With a portfolio that includes three patents, Roth's research primarily focuses on methods for producing pneumococcal capsular polysaccharide carrier protein conjugates. His groundbreaking inventions have the potential to enhance vaccine formulations and ultimately improve public health outcomes.

Latest Patents

Roth’s latest patents detail advanced methodologies for the production of polysaccharide carrier protein conjugates. One of his notable inventions is titled "Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres." This method involves the separate lyophilization of activated pneumococcal polysaccharides and carrier proteins into lyospheres, which are subsequently mixed and reconstituted to create efficacious vaccine components. Another significant patent, "Methods for producing capsular polysaccharide carrier protein conjugates," outlines a similar approach where reconstituted components are combined to produce multivalent immunogenic compositions intended for vaccine development. These methods reflect Roth's commitment to enhancing the effectiveness of pneumococcal vaccines through innovative techniques.

Career Highlights

Throughout his career, Daniel D. Roth has not only focused on the technical aspects of immunology but has also contributed to the scientific community through his role at Merck Sharp & Dohme Corporation. His patents represent a vital step forward in the development of pneumococcal vaccines, aiming to offer better protection against pneumococcal diseases. With three patents to his name, Roth has established himself as a key figure in vaccine innovation.

Collaborations

In his pursuit of scientific advancement, Roth has collaborated closely with esteemed colleagues such as Akhilesh Bhambhani and Christopher Jon Farrell. These partnerships reflect a team-oriented approach to research, facilitating the sharing of ideas and expertise to foster innovation in vaccine development.

Conclusion

Daniel D. Roth's contributions to the field of immunology, particularly through his patents on pneumococcal capsular polysaccharide carrier protein conjugates, illustrate his significant impact on vaccine innovation. As he continues his work at Merck Sharp & Dohme Corporation, Roth remains a vital asset in the fight against infectious diseases, showcasing the importance of collaboration and innovation in improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…